By Peter Gaskin, Principal Consultant at Aptuit Consulting
The European Medicines Agency (EMA) adopted the Guideline on Similar Biological Medical Products in 2005 and the first biosimilar product (Omnitrope; Sandoz GmbH, Switzerland) was subsequently marketed in Europe in 2006.
1,2 The guideline still provides overarching guidance, but since ...
Read Article